Literature DB >> 14733734

SARS: lessons learned from other coronaviruses.

Sonia Navas-Martin1, Susan R Weiss.   

Abstract

The identification of a new coronavirus as the etiological agent of severe acute respiratory syndrome (SARS) has evoked much new interest in the molecular biology and pathogenesis of coronaviruses. This review summarizes present knowledge on coronavirus molecular biology and pathogenesis with particular emphasis on mouse hepatitis virus (MHV). MHV, a member of coronavirus group 2, is a natural pathogen of the mouse; MHV infection of the mouse is considered one of the best models for the study of demyelinating disease, such as multiple sclerosis, in humans. As a result of the SARS epidemic, coronaviruses can now be considered as emerging pathogens. Future research on SARS needs to be based on all the knowledge that coronavirologists have generated over more than 30 years of research.

Entities:  

Mesh:

Year:  2003        PMID: 14733734     DOI: 10.1089/088282403771926292

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  21 in total

1.  The nsp1, nsp13, and M proteins contribute to the hepatotropism of murine coronavirus JHM.WU.

Authors:  Rong Zhang; Yize Li; Timothy J Cowley; Adam D Steinbrenner; Judith M Phillips; Boyd L Yount; Ralph S Baric; Susan R Weiss
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

2.  Lineage A Betacoronavirus NS2 Proteins and the Homologous Torovirus Berne pp1a Carboxy-Terminal Domain Are Phosphodiesterases That Antagonize Activation of RNase L.

Authors:  Stephen A Goldstein; Joshua M Thornbrough; Rong Zhang; Babal K Jha; Yize Li; Ruth Elliott; Katherine Quiroz-Figueroa; Annie I Chen; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2017-02-14       Impact factor: 5.103

3.  Identification of a novel coronavirus in bats.

Authors:  L L M Poon; D K W Chu; K H Chan; O K Wong; T M Ellis; Y H C Leung; S K P Lau; P C Y Woo; K Y Suen; K Y Yuen; Y Guan; J S M Peiris
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.

Authors:  Sonia Navas-Martin; Susan T Hingley; Susan R Weiss
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Activation of RNase L by Murine Coronavirus in Myeloid Cells Is Dependent on Basal Oas Gene Expression and Independent of Virus-Induced Interferon.

Authors:  L Dillon Birdwell; Zachary B Zalinger; Yize Li; Patrick W Wright; Ruth Elliott; Kristine M Rose; Robert H Silverman; Susan R Weiss
Journal:  J Virol       Date:  2016-01-06       Impact factor: 5.103

6.  Molecular determinants for subcellular localization of the severe acute respiratory syndrome coronavirus open reading frame 3b protein.

Authors:  Eric C Freundt; Li Yu; Elizabeth Park; Michael J Lenardo; Xiao-Ning Xu
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

7.  Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.

Authors:  Himani Bisht; Anjeanette Roberts; Leatrice Vogel; Alexander Bukreyev; Peter L Collins; Brian R Murphy; Kanta Subbarao; Bernard Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

8.  SARS coronavirus unique domain: three-domain molecular architecture in solution and RNA binding.

Authors:  Margaret A Johnson; Amarnath Chatterjee; Benjamin W Neuman; Kurt Wüthrich
Journal:  J Mol Biol       Date:  2010-05-21       Impact factor: 5.469

9.  The Severe Acute Respiratory Syndrome (SARS)-coronavirus 3a protein may function as a modulator of the trafficking properties of the spike protein.

Authors:  Yee-Joo Tan
Journal:  Virol J       Date:  2005-02-10       Impact factor: 4.099

10.  Identification of a new region of SARS-CoV S protein critical for viral entry.

Authors:  Ying Guo; Jennifer Tisoncik; Susanna McReynolds; Michael Farzan; Bellur S Prabhakar; Thomas Gallagher; Lijun Rong; Michael Caffrey
Journal:  J Mol Biol       Date:  2009-10-21       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.